ADAM17 is upregulated in colorectal cancer cells (Blanchot‐Jossic et al., 2005) and blocking ADAM17 in mouse colorectal cancer xenografts inhibited tumor growth (Rios‐Doria et al., 2015). Here, ADAM17 is linked to colorectal cancer.